The introduction of the drug-eluting stent (DES) proved to be an important step forward in
reducing rates of restenosis and target lesion revascularization after percutaneous coronary …

Coronary artery stents revolutionized the practice of interventional cardiology after they were
first introduced in the mid-1980s. Since then, there have been significant developments in …

Objectives: The purpose of this study was to investigate the appropriateness of stenting a
functionally nonsignificant stenosis. Background: Percutaneous coronary intervention (PCI) …

Aims Acute coronary syndromes (ACS) are mostly caused by plaque rupture. This study
aims to investigate the prognostic value of in vivo detection of high-risk coronary plaques by …

Background Stent thrombosis is a safety concern associated with use of drug-eluting stents.
Little is known about occurrence of stent thrombosis more than 1 year after implantation of …

In patients with stable CAD, PCI can be considered a valuable initial mode of
revascularization in all patients with objective large ischaemia in the presence of almost …

The ACC/AHA Task Force on Practice Guidelines was formed to gather information and
make recommendations about appropriate use of technology for the diagnosis and …

Objectives: We sought to define the incidence of late clinical events and late stent
thrombosis in patients treated with drug-eluting (DES) versus bare-metal stents (BMS) after …

Percutaneous Coronary Intervention (PCI) is currently the most conventional and effective
method for clinically treating cardiovascular diseases such as atherosclerosis. Stent …

At present, 90 to 95 percent of percutaneous coronary interventions involve the implantation
of a stent, often a drug-eluting stent, though most published data originated in the era of bare …